J.L. García Garmendia

Author

Hospital Universitario Virgen del Rocío ORCID

Also Known As

A. Horton, Beatriz García, E. Kirchner, Elena Gallego, Elena Gallego Curto, García-Garmendia, José L., J. García, J. García-Garmendia, J. Garmendia, J. L. Garcia Garmendia

Publications

4.6K

Citations

H-Index

Concepts

All Affiliations

Hospital Universitario Virgen del Rocío Hospital Universitario Virgen Macarena Hospital Universitario de Valme Hospital Universitario Reina Sofía Centro de Investigación Biomédica en Red de Enfermedades Respiratorias

About

J.L. García Garmendia is an author at Hospital Universitario Virgen del Rocío specializing in medicine, sepsis, and antibiotics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	11	1.9K
2	Health Sciences	3	3	1K
3	Critical Care Medicine	2	2	434
4	Clinical Nutrition	1	1	46
5	Emergency Medicine	1	1	223

J.L. García Garmendia

Publications

3.7K

Citations

H-Index

Page 1

	Year	Citations
Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis* José Garnacho‐Montero, J.L. García Garmendia, A Barrero-Almodóvar, Critical Care Medicine	2003	717
Treatment of Multidrug‐Resistant<i>Acinetobacter baumannii</i>Ventilator‐Associated Pneumonia (VAP) with Intravenous Colistin: A Comparison with Imipenem‐Susceptible VAP José Garnacho‐Montero, Carlos Ortíz-Leyba, F. J. Jiménez-Jiménez, Clinical Infectious Diseases Antimicrobial SusceptibilityHealth SciencesAntibioticsImipenem‐susceptible VapIntravenous Colistin	2003	468
Critical illness polyneuropathy: risk factors and clinical consequences. A cohort study in septic patients José Garnacho‐Montero, Juan Madrazo-Osuna, J.L. García Garmendia, Intensive Care Medicine Critical Care MedicineClinical ConsequencesAcute CareClinical EpidemiologyPatient Safety	2001	399
Bacteremia Due to Acinetobacter baumannii: Epidemiology, Clinical Findings, and Prognostic Features José Miguel Cisneros, M. J. Reyes, Jerónimo Pachón, Clinical Infectious Diseases Antimicrobial SusceptibilityHealth SciencesAntibioticsMicrobial DiseaseHealthcare-associated Infection	1996	345
Incidence and outcome of invasive candidiasis in intensive care units (ICUs) in Europe: results of the EUCANDICU project Matteo Bassetti, Daniele Roberto Giacobbe, Antonio Vena, Critical Care	2019	227
Risk Factors for<i>Acinetobacter baumannii</i>Nosocomial Bacteremia in Critically Ill Patients: A Cohort Study J.L. García Garmendia, Carlos Ortíz-Leyba, José Garnacho‐Montero, Clinical Infectious Diseases Critically Ill PatientsAntimicrobial StewardshipHealthcare-associated InfectionInvasive ProceduresSepsis	2001	223
Mortality and morbidity attributable to inadequate empirical antimicrobial therapy in patients admitted to the ICU with sepsis: a matched cohort study José Garnacho‐Montero, Carlos Ortíz-Leyba, Inmaculada Concepción Herrera-Melero, Journal of Antimicrobial Chemotherapy	2007	199
Influence of Erythrocyte Concentrate Storage Time on Postsurgical Morbidity in Cardiac Surgery Patients Santiago R. Leal‐Noval, Irene Jara‐López, J.L. García Garmendia, Anesthesiology	2003	197
Comparison of intravenous flecainide, propafenone, and amiodarone for conversion of acute atrial fibrillation to sinus rhythm Francisco Javier Martínez‐Marcos, J.L. García Garmendia, Antonio Ortega-Carpio, The American Journal of Cardiology ThrombosisCardiac AnaesthesiaCardiovascular DiseaseIntravenous FlecainideMedicine	2000	172
Mortality and the increase in length of stay attributable to the acquisition of Acinetobacter in critically ill patients J.L. García Garmendia, Carlos Ortíz-Leyba, José Garnacho‐Montero, Critical Care Medicine	1999	121

Page 1